At the time of writing, Solid Biosciences Inc [SLDB] stock is trading at $4.03, up 2.28%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SLDB shares have gain 39.93% over the last week, with a monthly amount glided 28.34%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Solid Biosciences Inc [NASDAQ: SLDB] stock has seen the most recent analyst activity on January 08, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $16. Previously, Wedbush started tracking the stock with Outperform rating on December 13, 2024, and set its price target to $16. On December 10, 2024, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $15 on the stock. JP Morgan upgraded its rating to a Overweight and increased its price target to $15 on July 15, 2024. Leerink Partners upgraded its rating to a Outperform but $12 remained the price target by the analyst firm on June 24, 2024. In a note dated March 28, 2024, William Blair initiated an Outperform rating and provided a target price of $40 on this stock.
For the past year, the stock price of Solid Biosciences Inc fluctuated between $2.88 and $15.05. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. Solid Biosciences Inc [NASDAQ: SLDB] shares were valued at $4.03 at the most recent close of the market. An investor can expect a potential return of 334.24% based on the average SLDB price forecast.
Analyzing the SLDB fundamentals
Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -23.67%, Pretax Profit Margin comes in at -21.63%, and Net Profit Margin reading is -21.63%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.59 and Total Capital is -0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.89 points at the first support level, and at 3.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.21, and for the 2nd resistance point, it is at 4.39.
Ratios To Look Out For
It is important to note that Solid Biosciences Inc [NASDAQ:SLDB] has a current ratio of 7.85. As well, the Quick Ratio is 7.85, while the Cash Ratio is 2.82.
Transactions by insiders
Recent insider trading involved Howton David T, Officer, that happened on Feb 14 ’25 when 5561.0 shares were purchased. Officer, Herzich Paul completed a deal on Feb 14 ’25 to buy 2688.0 shares. Meanwhile, Officer Tan Kevin bought 3164.0 shares on Feb 14 ’25.
